AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
72 hedge funds and large institutions have $18M invested in Accelerate Diagnostics in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
65% less call options, than puts
Call options by funds: $52K | Put options by funds: $148K
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
72
Holding in Top 10
–
Calls
$52K
Puts
$148K
Top Buyers
| 1 | +$894K | |
| 2 | +$352K | |
| 3 | +$156K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$57K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.6K |
Top Sellers
| 1 | -$684K | |
| 2 | -$456K | |
| 3 | -$410K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$352K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$288K |